Page 23 - Imprint-magazine june-Issue

Business News

DGHS approves Vivimed Labs to manufacture, market

Favipiravir tablets in India

Favipiravir is one of the leading oral anti-viral treatment approved in
various countries for the potential treatment of patients with mild to moderate
Covid-19 disease

Drug firm Vivimed Labs on May Favipiravir tablets in India, used approval to manufacture and
10, said it has received for the treatment of mild to market Favipiravir tablets in
approval from the Director moderate cases of Covid-19. the strengths of 200 mg and
General of Health Services Vivimed Labs in receipt of Gov- 400 mg under Vivimed’s own
(DGHS) to manufacture and ernment of India (DGHS) brand name Read More
market

Pfizer too refused direct supply of Covid vaccine to

Punjab

On Sunday, state officials had said US-based vaccine manufacturer Moderna

had refused to send vaccines directly to Punjab

After Moderna, Pfizer too has said US-based vaccine manu- any private party and state.
refused to supply coronavirus facturer Moderna had refused
vaccines directly to the Punjab to send vaccines directly to Punjab’s nodal officer for vac-
government, saying it only Punjab, citing the company cination and senior IAS officer
deals with the Centre. policy that it deals with the Vikas Garg on Monday said
On Sunday, state officials had Government of India, not with Read More

RDIF evince interest in Telangana’s global tender for

Covid vaccine

Telangana recently issued a global-tender notice for procuring ten million

doses of COVID-19 vaccine from manufacturers or their agents in case of
imported jabs.

As per sources, AstraZeneca government for procuring 10 The pre-bid meeting was held on
and Russia’s Sputnik V are the million doses of Covid-19 May 26.
only two vaccine vaccine, though the conference
manufacturers which have witnessed participation of a few The last date to submit the
participated in a pre-bid trade representatives. quotation is June 4.
meeting held by Telangana Read More

JUNE-2021 21